Products of other enterprises
Description
Dacogen® (decitabine) for Injection is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory nemia with ringed sideroblasts, refractory nemia with excess blasts, refractory anemia with excess blasts in transformation, chronic myelomonocytic leukemia) and intermediate-1, intermediate-2 and high-risk International Prognostic Scoring System (IPSS) groups.
Dacogen (decitabine) is a cancer medication that interferes with the growth and spread of cancer cells in the body.
Dacogen may also be used for purposes not listed in this medication guide.
Contact the seller
MDS syndrome treatment, Dacogen
We recommend to see